Cardiac Wire #18 September 11, 2022
GRACE 3.0: Correcting the Default Male Risk | Biosense Webster’s OCTARAY
Cardiac Wire #17 September 2, 2022
Medtronic’s Defibrillation Innovation | ESC Study Drop
Cardiac Wire #16 August 31, 2022
ESC Study Surge | CV Health Goes Digital
Cardiac Wire #15 August 28, 2022
Statin Guideline Debate | Sudden Cardiac Death Genes
Cardiac Wire #14 August 24, 2022
Obesity Paradox Bias | COVID Heart Insights
Cardiac Wire #13 August 21, 2022
Echo Clues: Predicting Cardiac Amyloidosis | New Ventricular Tachycardia Treatment
Cardiac Wire #12 August 17, 2022
Clinician ‘Algorithm Aversion’ in HF Care | Dyad’s AI Echo Clearance
Cardiac Wire #11 August 12, 2022
For Genetic Tests, Size Matters | Reva’s Revival
Cardiac Wire #10 August 10, 2022
Heating Up: Two Heart Medications Increase Risk | Smart Heart Scale
Cardiac Wire #9 August 5, 2022
Physiological Pacing Momentum | Stiff Heart Breakthrough
Cardiac Wire #8 August 3, 2022
Alnylam’s Promising HF Treatment | The Dangers of Post-Op AFib
Cardiac Wire #7 July 29, 2022
Why Men Die Earlier | Caption & HeartBeat’s Virtual Pathway 
Cardiac Wire #6 July 27, 2022
Rosuvastatin & Kidney Risks | Cleerly’s Massive Funding Round
Cardiac Wire #5 July 24, 2022
Cardiac Inconsistencies | Two COVID Myocarditis Types
Cardiac Wire #4 July 20, 2022
Race and Cardiovascular Health | DVT Risk Insights
Cardiac Wire #3 July 15, 2022
Medtronic & CathWorks Tighten Ties | Smart Wars
Cardiac Wire #2 July 13, 2022
REDUCE-IT Concerns Reignited | Smarter Murmer Detection
Cardiac Wire #1 July 8, 2022
Cancer Survivors’ CVD Risks | Translating Heart Failure Care
Cardiac Wire July 5, 2022
